Cargando…

Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al

Detalles Bibliográficos
Autores principales: Zhou, Yuchi, Liu, Xiangting, Wang, Xia, Li, Hui, Zeng, Guangting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378246/
https://www.ncbi.nlm.nih.gov/pubmed/35981692
http://dx.doi.org/10.1016/j.cmi.2022.07.028
_version_ 1784768516694474752
author Zhou, Yuchi
Liu, Xiangting
Wang, Xia
Li, Hui
Zeng, Guangting
author_facet Zhou, Yuchi
Liu, Xiangting
Wang, Xia
Li, Hui
Zeng, Guangting
author_sort Zhou, Yuchi
collection PubMed
description
format Online
Article
Text
id pubmed-9378246
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-93782462022-08-16 Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al Zhou, Yuchi Liu, Xiangting Wang, Xia Li, Hui Zeng, Guangting Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022-12 2022-08-16 /pmc/articles/PMC9378246/ /pubmed/35981692 http://dx.doi.org/10.1016/j.cmi.2022.07.028 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Zhou, Yuchi
Liu, Xiangting
Wang, Xia
Li, Hui
Zeng, Guangting
Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al
title Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al
title_full Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al
title_fullStr Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al
title_full_unstemmed Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al
title_short Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al
title_sort re: ‘association between igg antibody levels and adverse events after first and second bnt162b2 mrna vaccine doses’ by braun et al
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378246/
https://www.ncbi.nlm.nih.gov/pubmed/35981692
http://dx.doi.org/10.1016/j.cmi.2022.07.028
work_keys_str_mv AT zhouyuchi reassociationbetweeniggantibodylevelsandadverseeventsafterfirstandsecondbnt162b2mrnavaccinedosesbybraunetal
AT liuxiangting reassociationbetweeniggantibodylevelsandadverseeventsafterfirstandsecondbnt162b2mrnavaccinedosesbybraunetal
AT wangxia reassociationbetweeniggantibodylevelsandadverseeventsafterfirstandsecondbnt162b2mrnavaccinedosesbybraunetal
AT lihui reassociationbetweeniggantibodylevelsandadverseeventsafterfirstandsecondbnt162b2mrnavaccinedosesbybraunetal
AT zengguangting reassociationbetweeniggantibodylevelsandadverseeventsafterfirstandsecondbnt162b2mrnavaccinedosesbybraunetal